Marilyn Reynolds

Marilyn Reynolds serves as the Program Point of Contact for the Centers for Disease Control and Prevention, playing a critical role in aligning procurement activities with the agency’s public health mission. She facilitates the acquisition of specialized laboratory instruments, diagnostic technologies, and analytical services essential to disease surveillance, outbreak response, and national laboratory capacity building. Her work bridges programmatic needs with contracting execution, ensuring timely delivery of mission-critical equipment and technical services. She typically handles complex, high-precision procurements under FAR Part 15, often involving technical evaluations, performance-based specifications, and long-term service agreements with industry partners. Reynolds maintains sustained relationships with leading global pharmaceutical and medical distribution entities, including Merck Sharp & Dohme LLC, GlaxoSmithKline LLC, Pfizer Inc., Sanofi Pasteur Inc., and McKesson Specialty Distribution LLC. These partnerships center on the procurement of vaccines, diagnostic reagents, cold chain logistics, and laboratory supply chains critical to national immunization and emergency response programs. Her contracting approach emphasizes reliability, regulatory compliance, and supply chain resilience, reflecting the CDC’s need for uninterrupted access to biologics and diagnostic tools during public health emergencies. Her procurement patterns show a strong preference for full and open competition, with 93.6% of awards issued without set-asides, indicating a focus on technical capability over socioeconomic categorization. Only 6.4% of awards are designated as total small business set-asides under FAR 19.5, suggesting that while small business participation is recognized, it is secondary to the specialized nature of the required goods and services. The overwhelming majority of her acquisitions—74.4%—fall under NAICS 334516 for analytical laboratory instrument manufacturing, reflecting deep expertise in procuring high-end diagnostic equipment such as PCR sequencers, mass spectrometers, and automated biosafety systems. Additional procurements include computer systems design and specialized analytical services supporting real-time epidemiological data integration, underscoring her technical proficiency in public health diagnostics and laboratory informatics.